| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 4,651 | 3,440 | 3,766 | 2,651 | | Selling General and Administrative | 2,351 | 2,355 | 3,090 | 2,269 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,002) | (5,795) | (6,856) | (4,920) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 158 | 123 | 171 | 2,078 | | Earnings Before Interest And Taxes | (6,844) | (5,672) | (6,685) | (2,842) | | Interest Expense | 139 | 136 | 361 | 170 | | Income Before Tax | (6,983) | (5,808) | (7,046) | (3,012) | | Income Tax Expense |
-
|
-
|
-
| (2,765) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,983) | (5,808) | (7,046) | (247) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (2,138) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,983) | (5,808) | (7,046) | (2,385) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,983) | ($5,808) | ($7,046) | ($2,385) |
|
0.51% Nasdaq 
0.30 (5.86%) 
Income Statement
